2025 Year-End Patient Centricity Review

Progress and Perspectives in Patient Centricity: 2025 Reflections

Patient centricity is a movement now. At Cactus Life Sciences, we don’t just follow the trend; we help set it. Here’s how your voices, our actions, and the industry’s bold steps made 2025 a landmark year...
Read More

Top Stories

Patient Centricity

The Evolution of Patient Centricity in Pharma

Patient centricity: A defining imperative in healthcare As...
AI in Scientific Publications

The Role of AI in Transforming Scientific

Scientific publishing is evolving rapidly with the advent of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...

“Voice of Patient” in Publications: Trends and Perspectives

This page contains a poster presented at the 21st Annual Meeting of ISMPP (International Society for Medical Publication...
Empowering Medical Affairs by Leveraging Modular Content

Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content

In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...
plain language summaries and genAI

Readability of Published vs. Artificial Intelligence (AI)-Generated Plain-Language Summaries (PLS)

PLS play an important role in increasing the accessibility of medical publications to a wide...
Audiovisual medical publication content and formats

Use of Audiovisual Data Dissemination Formats (ADDFs) by Medical Journals: Then and Now 

GPP 2022 guidelines endorse the use of alternative data dissemination formats, including ADDFs, to enhance...
Omnichannel

The Quest for Omnichannel: Is Medical Affairs Ready?

Commercial and Medical Affairs must partner with each other to achieve the real benefits of...
Artificial Intelligence and Writing

Breaking Barriers: Exploring the Power of AI and NLP in Scientific Communication

Learn how medical publication professionals and medical affairs teams can embrace AI and NLP tools...

Learn more ABOUT our company.